Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/115617
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGizaw, Muluken-
dc.contributor.authorParkin, Donald Maxwell-
dc.contributor.authorStöter, Ole-
dc.contributor.authorBukirwa, Phiona-
dc.contributor.authorSeife, Edom-
dc.contributor.authorChesumbai, Gladys-
dc.contributor.authorKorir, Anne-
dc.contributor.authorLiu, Biying-
dc.contributor.authorManraj, Shyam S.-
dc.contributor.authorNda, Guy-
dc.contributor.authorSomdyala, Nontuthuzelo I. M.-
dc.contributor.authorKantelhardt, Eva Johanna-
dc.date.accessioned2024-04-10T06:39:38Z-
dc.date.available2024-04-10T06:39:38Z-
dc.date.issued2024-
dc.identifier.urihttps://opendata.uni-halle.de//handle/1981185920/117572-
dc.identifier.urihttp://dx.doi.org/10.25673/115617-
dc.description.abstractOvarian cancer (OC) is the fourth most common cancer of women in sub-Saharan Africa (SSA), although few data have been published on population-level survival. We estimate ovarian cancer survival in SSA by human development index and histological subtype, using data from seven population-based cancer registries in six countries: Kenya (Nairobi and Eldoret), Mauritius, Uganda (Kampala), Cote d'Ivoire (Abidjan), Ethiopia (Addis Ababa) and South Africa (Eastern Cape). A total of 644 cases diagnosed during 2008–2014 were included, with 77% being of epithelial subtypes (range 47% [Abidjan]—80% [Mauritius]). The overall observed survival in the study cohort was 73.4% (95% CI: 69.8, 77.0) at 1 year, 54.4% (95% CI: 50.4, 58.7) at 3 years and 45.0% (95% CI: 41.0, 49.4) at 5 years. Relative survival at Year 1 ranged from 44.4% in Kampala to 86.3% in Mauritius, with a mean for the seven series of 67.4%. Relative survival was highest in Mauritius at 72.2% and lowest in Kampala, Uganda at 19.5%, with a mean of 47.8%. There was no difference in survival by age at diagnosis. Patients from high and medium HDI countries had significantly better survival than those from low HDI countries. Women with cancers of epithelial cell origin had much lower survival compared to women with other histological subtypes (p = .02). Adjusted for the young age of the African patients with ovarian cancer (44% aged <50) survival is much lower than in USA or Europe, and underlines the need for improvements in the access to diagnosis and treatment of OC in SSA.eng
dc.language.isoeng-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.subject.ddc610-
dc.titleOvarian cancer survival in sub-Saharan Africa by human development index and histological subtypes: A population-based registry studyeng
dc.typeArticle-
local.versionTypepublishedVersion-
local.bibliographicCitation.journaltitleInternational journal of cancer-
local.bibliographicCitation.volume154-
local.bibliographicCitation.issue11-
local.bibliographicCitation.pagestart1911-
local.bibliographicCitation.pageend1919-
local.bibliographicCitation.publishernameWiley-Liss-
local.bibliographicCitation.publisherplaceBognor Regis-
local.bibliographicCitation.doi10.1002/ijc.34877-
local.openaccesstrue-
dc.identifier.ppn1885445326-
cbs.publication.displayform2024-
local.bibliographicCitation.year2024-
cbs.sru.importDate2024-04-10T06:39:12Z-
local.bibliographicCitationEnthalten in International journal of cancer - Bognor Regis : Wiley-Liss, 1966-
local.accessrights.dnbfree-
Appears in Collections:Open Access Publikationen der MLU